(Q73850451)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837698%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Intranasal insulin delivery and therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837698%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Hinchcliffe M

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837698%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Illum L

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837698%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837698%20AND%20SRC:MED&resulttype=core&format=json

Advanced Drug Delivery Reviews

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837698%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837698%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837698%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

199-234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837698%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

cites work

The history of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Recent developments in insulin delivery techniques. Current status and future potential

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Intranasal drug delivery. Potential advantages and limitations from a clinical pharmacokinetic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Monomeric insulins and their experimental and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Intranasal insulin. Clinical pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Nasal delivery. The use of animal models to predict performance in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Clearance of Inhaled Particles From the Human Nose

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

The propulsion of mucus by cilia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Drug metabolism in the nasal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Enkephalin hydrolysis in homogenates of various absorptive mucosae of the albino rabbit: similarities in rates and involvement of aminopeptidases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Hydrolysis of peptides in the nasal cavity of humans

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Immunobarriers of the mucosa of the upper respiratory and digestive pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Bioadhesive microspheres as a potential nasal drug delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

The nasal mucociliary clearance: relevance to nasal drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Distribution and removal of human serum albumin-technetium 99m instilled intranasally

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Intranasal drug delivery by spray and drops

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Nasal administration of desmopressin by spray and drops

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Effects of concentration and volume on nasal bioavailability and biological response to desmopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Effect of Viscosity on Particle Size, Deposition, and Clearance of Nasal Delivery Systems Containing Desmopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Effect of viscosity on the pharmacokinetics and biological response to intranasal desmopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

The nasal distribution of metered dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

The distribution of an intranasal insulin formulation in healthy volunteers: effect of different administration techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Nasal delivery of a vasopressin antagonist in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Nasal Mucociliary Clearance Under Various Conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Nasal mucociliary function in different diseases of the nose.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Pharmacokinetics of intranasally applied medication during a cold

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Sidestream tobacco smoke exposure acutely alters human nasal mucociliary clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Nasal absorption of caerulein.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Effect of intranasal histamine on nasal mucosal blood flow and the antidiuretic activity of desmopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Is mucus a selective barrier to macromolecules?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Use of a biophysical-kinetic model to understand the roles of protein binding and membrane partitioning on passive diffusion of highly lipophilic molecules across cellular barriers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Nasal Absorption of Propranolol in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Nasal absorption of propranolol in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Nasal absorption of propranolol from different dosage forms by rats and dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Nasal absorption of 17 alpha-ethinyloestradiol in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

The effect of molecular size on the nasal absorption of water-soluble compounds in the albino rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Di-iodo-L-tyrosine-labelled dextrans as molecular size markers of nasal absorption in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Lipophilic peptides: synthesis of lauroyl thyrotropin-releasing hormone and its biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Mechanism of nasal absorption of drugs. III: Nasal absorption of leucine enkephalin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Effect of sodium glycocholate and polyoxyethylene-9-lauryl ether on the hydrolysis of varying concentrations of insulin in the nasal homogenates of the albino rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Study of nasal enzyme activity towards insulin. In vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Synthesis of palmitoyl derivatives of insulin and their biological activities

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

The nasal delivery of peptides and proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Micelle formation by bile salts. Physical-chemical and thermodynamic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Bile salt-fatty acid mixed micelles as nasal absorption promoters of peptides. II. In vivo nasal absorption of insulin in rats and effects of mixed micelles on the morphological integrity of the nasal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Nasal absorption of insulin: enhancement by hydrophobic bile salts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Effects of intranasal insulin in non-obese type II diabetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Long-term use of intranasal insulin in insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Preprandial intranasal insulin as adjuvant therapy in type II diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Preprandial intranasal insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Biological activity of nasally administered insulin in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Intranasal insulin administration in insulin dependent diabetes: reproducibility of its absorption and effects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Meal-time Intranasal Insulin Delivery in Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Effect of bile salts on the rectal absorption of sodium ampicillin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Differences in the promotion mechanism of the colonic absorption of antipyrine, phenol red and cefmetazole

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Direct effect of bile salts and phospholipids on the physical properties of mucus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Nasal membrane and intracellular protein and enzyme release by bile salts and bile salt-fatty acid mixed micelles: correlation with facilitated drug transport

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Effect of bile salts on nasal permeability in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Effects of absorption enhancers on human nasal tissue ciliary movement in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Solubilization of membranes by detergents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Site dependence of absorption-promoting actions of laureth-9, Na salicylate, Na2EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Mechanisms of Surfactant Effects on Drug Absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

The effects of permeation enhancers on the surface morphology of the rat nasal mucosa: a scanning electron microscopy study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

The molecular weight dependence of nasal absorption: the effect of absorption enhancers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Bioavailability of leuprolide acetate following nasal and inhalation delivery to rats and healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Cellular mechanism of intestinal permeability alterations produced by chelation depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

The Use of a Radiolabelled Saccharin Solution to Monitor the Effect of the Preservatives Thiomersal, Benzalkonium Chloride and EDTA on Human Nasal Clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Studies on the promoting effects of medium chain fatty acid salts on the nasal absorption of insulin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Lysophospholipids as biosurfactants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Nasal absorption in the rat. III. Effect of lysophospholipids on insulin absorption and nasal histology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Intranasal Administration of Insulin With Phospholipid as Absorption Enhancer: Pharmacokinetics in Normal Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Intranasal insulin therapy: the clinical realities

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Studies on the mechanism of hemolysis by acyl carnitines, lysolecithins and acyl cholines.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Bile salt- and lysophosphatidylcholine-induced membrane damage in human erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Nasal absorption enhancers for biosynthetic human growth hormone in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Inhibition of the enzymatic degradation of Leu--enkephalin by puromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Apropos aprotinin: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Promotion of nasal absorption of insulin by glycyrrhetinic acid derivatives. I

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Nasal insulin delivery with dimethyl-beta-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

The effect of cyclodextrins on the stability of peptides in nasal enzymic systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Effects of absorption enhancers on rat nasal epithelium in vivo: release of marker compounds in the nasal cavity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Starch microspheres induce pulsatile delivery of drugs and peptides across the epithelial barrier by reversible separation of the tight junctions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Chitosan as a novel nasal delivery system for peptide drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

A role for anionic sites in epithelial architecture. Effects of cationic polymers on cell membrane structure

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900073-8

7 January 2021

10.1016/S0169-409X(98)00073-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837698%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference